{"gene":"GNAT1","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2007,"finding":"The GNAT1 p.Gly38Asp mutation produces an alpha-transducin that is unable to activate its downstream effector molecule in vitro, establishing a loss-of-effector-activation mechanism for autosomal dominant CSNB.","method":"In vitro biochemical assay (effector activation assay referenced as previously published data, cited in context of new mutation analysis)","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — referenced in vitro functional data combined with trypsin protection assay and structural modeling in the same paper; single lab","pmids":["17584859"],"is_preprint":false},{"year":2007,"finding":"The GNAT1 p.Gln200Glu substitution in the Switch 2 region (GTPase active site) of alpha-transducin leads to impaired GTPase activity and constitutive activation of phototransduction, as supported by trypsin protection assays and structural modeling based on known crystal structure.","method":"Trypsin protection assay; computer modeling based on crystal structure of transducin; in vitro expression of Switch 2 mutants","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — trypsin protection assay plus structural modeling, single lab, two orthogonal methods but no direct GTPase measurement in this paper","pmids":["17584859"],"is_preprint":false},{"year":2009,"finding":"A nonsense mutation in Gnat1 (Tyr150Ter), caused by a 57-bp intronic deletion disrupting the splice donor site of intron 4, results in absence of rod transducin alpha-subunit (Tralpha) protein and rod dysfunction in IRD1 and IRD2 mice.","method":"Quantitative real-time RT-PCR; immunohistochemistry; western blot; cDNA sequencing; genomic sequencing","journal":"Experimental eye research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (RT-PCR, IHC, western blot, sequencing) confirming loss-of-function mechanism in two independent mouse strains","pmids":["19766629"],"is_preprint":false},{"year":2012,"finding":"A homozygous missense mutation p.D129G in GNAT1 segregates with autosomal recessive congenital stationary night blindness in a consanguineous Pakistani family, and Gnat1 is expressed predominantly in the retina starting around postnatal day 7.","method":"Genome-wide linkage analysis; Sanger sequencing; quantitative expression analysis in ocular tissues at different postnatal intervals","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic segregation with quantitative expression analysis; single lab, no in vitro functional reconstitution of mutant protein","pmids":["22190596"],"is_preprint":false},{"year":2015,"finding":"A homozygous truncating (complete loss-of-function) mutation in GNAT1 causes not only lifelong night blindness but also late-onset retinitis pigmentosa/retinal degeneration, establishing that complete absence of rod transducin alpha-subunit leads to progressive photoreceptor degeneration in addition to stationary dysfunction.","method":"Targeted next-generation sequencing of 182 retinopathy-associated genes; clinical characterization including visual field testing and fundus examination","journal":"The British journal of ophthalmology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — definitive loss-of-function allele with clinical phenotype corroborated by Gnat1 knockout mouse comparison; single case, no in vitro reconstitution","pmids":["26472407"],"is_preprint":false},{"year":2018,"finding":"A novel GNAT1 missense variant p.Ile52Asn (c.155T>A) causing adCSNB affects a predicted nuclear localization signal and the first alpha-helix of the protein, distant from the GTP-binding site; subcellular localization of this and other GNAT1 CSNB mutant proteins is unaltered in mammalian overexpressing cells, indicating a mechanism distinct from mislocalization.","method":"Domain prediction; 3D structural modeling; subcellular localization assay in mammalian GNAT1-overexpressing cells; co-segregation by sequencing","journal":"BioMed research international","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — subcellular localization experiment in overexpressing cells plus structural modeling; single lab, limited functional reconstitution","pmids":["29850563"],"is_preprint":false},{"year":2022,"finding":"Gnat1 knockout mice (lacking rod alpha-transducin) combined with cone alpha-transducin-deficient (Gnat2) mice completely abolish rod and cone photoresponses as confirmed by ERG, yet robust visually evoked potentials persist, demonstrating that melanopsin-expressing ipRGCs can drive primary pattern-forming visual cortex responses independently of rod and cone transducin.","method":"Electroretinography (ERG); visually evoked potentials (VEP) in Gnat1-/-; Gnat2cpfl3/cpfl3 double-knockout mice","journal":"Frontiers in cellular neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with two orthogonal electrophysiological readouts (ERG and VEP) establishing complete functional abolition of rod/cone phototransduction via GNAT1/GNAT2 loss","pmids":["36605613"],"is_preprint":false},{"year":2025,"finding":"Sildenafil (PDE6 inhibitor) completely abolished visually evoked responses in Gnat1-deficient (rod-deficient, cone-only) retinas but not in Gnat2-deficient (cone-deficient, rod-only) retinas ex vivo, demonstrating that Sildenafil preferentially inhibits cone PDE6 and that cone-selective suppression of phototransduction is sufficient to abolish Off-pathway RGC signaling.","method":"Ex vivo multi-electrode array recordings from Gnat1 and Gnat2 knockout mouse retinas; pharmacological PDE6 inhibition with Sildenafil; flash and drifting-grating stimuli","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct pharmacological/genetic dissection using knockout models with electrophysiological readout; preprint, single lab","pmids":["bio_10.1101_2025.10.07.680926"],"is_preprint":true},{"year":2026,"finding":"The GNAT1 p.Gln200Arg variant (c.599A>G) in the Switch 2 GTPase active-site region is predicted by in silico analysis and structural modeling to impair GTPase activity and cause constitutively active signaling after photoactivation, causing autosomal dominant Riggs-type CSNB.","method":"In silico pathogenicity prediction tools; protein structural modeling; targeted NGS with Sanger sequencing confirmation; ERG","journal":"Documenta ophthalmologica. Advances in ophthalmology","confidence":"Low","confidence_rationale":"Tier 4 / Weak — mechanistic inference based solely on computational/structural modeling without in vitro biochemical validation; single family","pmids":["41954843"],"is_preprint":false}],"current_model":"GNAT1 encodes the alpha-subunit of rod transducin, a key GTPase in the rod phototransduction cascade; it couples photoactivated rhodopsin to downstream cGMP phosphodiesterase, and disease-causing mutations either abolish effector activation (p.G38D), impair GTPase activity causing constitutive activation (p.Q200E/R), or truncate the protein causing complete loss of rod phototransduction and, with full loss-of-function alleles, progressive rod-cone degeneration in addition to stationary night blindness."},"narrative":{"mechanistic_narrative":"GNAT1 encodes the alpha-subunit of rod transducin, the GTPase that couples photoactivated rhodopsin to the downstream cGMP phosphodiesterase effector in the rod phototransduction cascade [PMID:17584859, PMID:19766629]. Distinct disease-causing mutations map onto separable steps of this GTPase cycle: the p.Gly38Asp substitution yields a transducin unable to activate its downstream effector, defining a loss-of-effector-activation mechanism for autosomal dominant CSNB [PMID:17584859], whereas Switch 2 active-site substitutions (p.Gln200Glu, p.Gln200Arg) impair GTPase activity and produce constitutive, light-independent signaling [PMID:17584859, PMID:41954843]. Complete loss of the protein, whether by a splice-disrupting nonsense allele in mice or a truncating allele in humans, abolishes rod transducin protein and rod phototransduction and, when fully null, causes progressive rod-cone/retinal degeneration in addition to stationary night blindness [PMID:19766629, PMID:26472407]. GNAT1 is expressed predominantly in the retina from early postnatal development [PMID:22190596], and combined loss of rod (Gnat1) and cone (Gnat2) transducin abolishes all rod and cone electroretinographic responses while sparing melanopsin-driven ipRGC cortical responses, demonstrating that GNAT1 is required specifically for the rod arm of image-forming phototransduction [PMID:36605613]. CSNB-associated missense variants do not act through protein mislocalization, as their subcellular distribution is unaltered in overexpressing cells [PMID:29850563].","teleology":[{"year":2007,"claim":"Resolved how dominant CSNB mutations corrupt transducin function by separating an effector-activation defect from an active-site GTPase defect, establishing two distinct molecular mechanisms.","evidence":"In vitro effector activation data, trypsin protection assay, and structural modeling of p.G38D and Switch 2 p.Q200E mutants","pmids":["17584859"],"confidence":"Medium","gaps":["No direct GTPase rate measurement for the Q200E mutant in this work","Single lab; effector activation data referenced from prior work"]},{"year":2009,"claim":"Showed that disrupting Gnat1 splicing eliminates rod transducin alpha-subunit protein and abolishes rod function, providing an in vivo loss-of-function model.","evidence":"RT-PCR, immunohistochemistry, western blot, and sequencing of IRD1/IRD2 mice carrying a Tyr150Ter nonsense allele","pmids":["19766629"],"confidence":"High","gaps":["Does not address degeneration progression over time","Mechanism of dominant human alleles not modeled here"]},{"year":2012,"claim":"Extended the GNAT1 disease spectrum to autosomal recessive CSNB and defined the retinal, postnatal-onset expression of the gene.","evidence":"Linkage analysis and Sanger sequencing of a consanguineous family plus quantitative ocular expression profiling for the p.D129G allele","pmids":["22190596"],"confidence":"Medium","gaps":["No in vitro functional reconstitution of the D129G mutant","Biochemical consequence of D129G unresolved"]},{"year":2015,"claim":"Established that complete loss of rod transducin causes progressive retinal degeneration, not merely stationary night blindness, distinguishing null from hypomorphic outcomes.","evidence":"Targeted NGS and clinical characterization of a homozygous truncating allele, corroborated by knockout-mouse comparison","pmids":["26472407"],"confidence":"Medium","gaps":["Single case","Cellular mechanism linking transducin loss to degeneration not defined"]},{"year":2018,"claim":"Ruled out protein mislocalization as the mechanism for CSNB mutants, including a variant in a predicted NLS and the first alpha-helix distant from the GTP-binding site.","evidence":"Subcellular localization assays in GNAT1-overexpressing mammalian cells plus structural modeling of p.I52N and other mutants","pmids":["29850563"],"confidence":"Medium","gaps":["Overexpression context may not reflect rod outer segment trafficking","Functional consequence of I52N not biochemically measured"]},{"year":2022,"claim":"Demonstrated that GNAT1 is required for the rod arm of image-forming vision and that melanopsin ipRGCs can drive cortical responses independently of rod/cone transducin.","evidence":"ERG and VEP recordings in Gnat1-/-; Gnat2cpfl3/cpfl3 double-knockout mice","pmids":["36605613"],"confidence":"High","gaps":["Does not dissect rod versus cone contributions to specific behaviors","Human relevance of ipRGC-driven cortical signaling untested"]},{"year":2025,"claim":"Used Gnat1 versus Gnat2 knockout retinas to pharmacologically separate rod and cone PDE6 contributions to downstream RGC signaling.","evidence":"Ex vivo multi-electrode array recordings with Sildenafil PDE6 inhibition in Gnat1 and Gnat2 knockout retinas (preprint)","pmids":["bio_10.1101_2025.10.07.680926"],"confidence":"Medium","gaps":["Preprint, single lab","Addresses cone-pathway pharmacology rather than GNAT1 protein mechanism directly"]},{"year":2026,"claim":"Linked another Switch 2 active-site variant to dominant Riggs-type CSNB via predicted impaired GTPase activity and constitutive signaling.","evidence":"In silico pathogenicity prediction, structural modeling, targeted NGS/Sanger confirmation, and ERG for p.Q200R","pmids":["41954843"],"confidence":"Low","gaps":["Mechanistic inference is purely computational without in vitro biochemical validation","Single family"]},{"year":null,"claim":"How complete loss of rod transducin progresses from stationary dysfunction to photoreceptor degeneration, and the biochemical consequences of recessive missense alleles, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No reconstituted biochemistry for D129G or I52N alleles","Mechanism linking null transducin to degeneration uncharacterized","Q200R constitutive-activation claim awaits biochemical confirmation"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[1,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,2,6]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[2,6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1]}],"complexes":["rod transducin"],"partners":["RHO","PDE6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P11488","full_name":"Guanine nucleotide-binding protein G(t) subunit alpha-1","aliases":["Transducin alpha-1 chain"],"length_aa":350,"mass_kda":40.0,"function":"Functions as a signal transducer for the rod photoreceptor RHO. Required for normal RHO-mediated light perception by the retina (PubMed:22190596). Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs), such as the photoreceptor RHO. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Activated RHO promotes GDP release and GTP binding. Signaling is mediated via downstream effector proteins, such as cGMP-phosphodiesterase (By similarity)","subcellular_location":"Cell projection, cilium, photoreceptor outer segment; Membrane; Photoreceptor inner segment","url":"https://www.uniprot.org/uniprotkb/P11488/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNAT1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNAT1","total_profiled":1310},"omim":[{"mim_id":"619926","title":"KELCH-LIKE FAMILY, MEMBER 18; KLHL18","url":"https://www.omim.org/entry/619926"},{"mim_id":"616389","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G","url":"https://www.omim.org/entry/616389"},{"mim_id":"610445","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1","url":"https://www.omim.org/entry/610445"},{"mim_id":"610444","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3","url":"https://www.omim.org/entry/610444"},{"mim_id":"604863","title":"LECITHIN RETINOL ACYLTRANSFERASE; LRAT","url":"https://www.omim.org/entry/604863"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mid piece","reliability":"Approved"},{"location":"Principal piece","reliability":"Approved"},{"location":"End piece","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":1040.7}],"url":"https://www.proteinatlas.org/search/GNAT1"},"hgnc":{"alias_symbol":["CSNBAD3"],"prev_symbol":[]},"alphafold":{"accession":"P11488","domains":[{"cath_id":"3.40.50.300","chopping":"35-56_194-335","consensus_level":"high","plddt":96.3809,"start":35,"end":335},{"cath_id":"1.10.400.10","chopping":"58-164","consensus_level":"high","plddt":97.0427,"start":58,"end":164}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11488","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11488-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11488-F1-predicted_aligned_error_v6.png","plddt_mean":94.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNAT1","jax_strain_url":"https://www.jax.org/strain/search?query=GNAT1"},"sequence":{"accession":"P11488","fasta_url":"https://rest.uniprot.org/uniprotkb/P11488.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11488/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11488"}},"corpus_meta":[{"pmid":"22190596","id":"PMC_22190596","title":"GNAT1 associated with autosomal recessive congenital stationary night blindness.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22190596","citation_count":66,"is_preprint":false},{"pmid":"27912775","id":"PMC_27912775","title":"A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27912775","citation_count":56,"is_preprint":false},{"pmid":"26472407","id":"PMC_26472407","title":"A novel homozygous truncating GNAT1 mutation implicated in retinal degeneration.","date":"2015","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/26472407","citation_count":36,"is_preprint":false},{"pmid":"17584859","id":"PMC_17584859","title":"p.Gln200Glu, a putative constitutively active mutant of rod alpha-transducin (GNAT1) in autosomal dominant congenital stationary night blindness.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17584859","citation_count":36,"is_preprint":false},{"pmid":"30132541","id":"PMC_30132541","title":"Long non‑coding RNA lnc‑GNAT1‑1 inhibits gastric cancer cell proliferation and invasion through the Wnt/β‑catenin pathway in Helicobacter pylori infection.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30132541","citation_count":21,"is_preprint":false},{"pmid":"31583501","id":"PMC_31583501","title":"Coexistence of GNAT1 and ABCA4 variants associated with Nougaret-type congenital stationary night blindness and childhood-onset cone-rod dystrophy.","date":"2019","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31583501","citation_count":18,"is_preprint":false},{"pmid":"27977773","id":"PMC_27977773","title":"Identification of a Novel Homozygous Nonsense Mutation Confirms the Implication of GNAT1 in Rod-Cone Dystrophy.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27977773","citation_count":18,"is_preprint":false},{"pmid":"30051303","id":"PMC_30051303","title":"Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association.","date":"2018","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/30051303","citation_count":13,"is_preprint":false},{"pmid":"19766629","id":"PMC_19766629","title":"A nonsense mutation in Gnat1, encoding the alpha subunit of rod transducin, in spontaneous mouse models of retinal dysfunction.","date":"2009","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19766629","citation_count":12,"is_preprint":false},{"pmid":"29850563","id":"PMC_29850563","title":"A Novel Heterozygous Missense Mutation in GNAT1 Leads to Autosomal Dominant Riggs Type of Congenital Stationary Night Blindness.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/29850563","citation_count":11,"is_preprint":false},{"pmid":"33193591","id":"PMC_33193591","title":"Long Non-coding RNA lnc-GNAT1-1 Suppresses Liver Cancer Progression via Modulation of Epithelial-Mesenchymal Transition.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33193591","citation_count":7,"is_preprint":false},{"pmid":"39349166","id":"PMC_39349166","title":"The Plastidial Protein Acetyltransferase GNAT1 Forms a Complex With GNAT2, yet Their Interaction Is Dispensable for State Transitions.","date":"2024","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/39349166","citation_count":6,"is_preprint":false},{"pmid":"17222360","id":"PMC_17222360","title":"[Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].","date":"2007","source":"Ai zheng = Aizheng = Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17222360","citation_count":6,"is_preprint":false},{"pmid":"36605613","id":"PMC_36605613","title":"Robust visual cortex evoked potentials (VEP) in Gnat1 and Gnat2 knockout mice.","date":"2022","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36605613","citation_count":4,"is_preprint":false},{"pmid":"35132885","id":"PMC_35132885","title":"Sleep Deprivation Does not Change the Flash Electroretinogram in Wild-type and Opn4 Mice.","date":"2022","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/35132885","citation_count":3,"is_preprint":false},{"pmid":"31696758","id":"PMC_31696758","title":"Novel homozygous in-frame deletion of GNAT1 gene causes golden appearance of fundus and reduced scotopic ERGs similar to that in Oguchi disease in Japanese family.","date":"2019","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31696758","citation_count":2,"is_preprint":false},{"pmid":"41954843","id":"PMC_41954843","title":"Autosomal dominant Riggs-type congenital stationary night blindness with fundus sheen and retinal atrophy due to a novel GNAT1 p.Gln200Arg variant.","date":"2026","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/41954843","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.07.680926","title":"Sildenafil-driven cone PDE6 inhibition alters receptive-field properties of retinal ganglion cells ex vivo","date":"2025-10-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.07.680926","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11958,"output_tokens":2263,"usd":0.03491,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9326,"output_tokens":2734,"usd":0.05749,"stage2_stop_reason":"end_turn"},"total_usd":0.0924,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"The GNAT1 p.Gly38Asp mutation produces an alpha-transducin that is unable to activate its downstream effector molecule in vitro, establishing a loss-of-effector-activation mechanism for autosomal dominant CSNB.\",\n      \"method\": \"In vitro biochemical assay (effector activation assay referenced as previously published data, cited in context of new mutation analysis)\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — referenced in vitro functional data combined with trypsin protection assay and structural modeling in the same paper; single lab\",\n      \"pmids\": [\"17584859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The GNAT1 p.Gln200Glu substitution in the Switch 2 region (GTPase active site) of alpha-transducin leads to impaired GTPase activity and constitutive activation of phototransduction, as supported by trypsin protection assays and structural modeling based on known crystal structure.\",\n      \"method\": \"Trypsin protection assay; computer modeling based on crystal structure of transducin; in vitro expression of Switch 2 mutants\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — trypsin protection assay plus structural modeling, single lab, two orthogonal methods but no direct GTPase measurement in this paper\",\n      \"pmids\": [\"17584859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A nonsense mutation in Gnat1 (Tyr150Ter), caused by a 57-bp intronic deletion disrupting the splice donor site of intron 4, results in absence of rod transducin alpha-subunit (Tralpha) protein and rod dysfunction in IRD1 and IRD2 mice.\",\n      \"method\": \"Quantitative real-time RT-PCR; immunohistochemistry; western blot; cDNA sequencing; genomic sequencing\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (RT-PCR, IHC, western blot, sequencing) confirming loss-of-function mechanism in two independent mouse strains\",\n      \"pmids\": [\"19766629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A homozygous missense mutation p.D129G in GNAT1 segregates with autosomal recessive congenital stationary night blindness in a consanguineous Pakistani family, and Gnat1 is expressed predominantly in the retina starting around postnatal day 7.\",\n      \"method\": \"Genome-wide linkage analysis; Sanger sequencing; quantitative expression analysis in ocular tissues at different postnatal intervals\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic segregation with quantitative expression analysis; single lab, no in vitro functional reconstitution of mutant protein\",\n      \"pmids\": [\"22190596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A homozygous truncating (complete loss-of-function) mutation in GNAT1 causes not only lifelong night blindness but also late-onset retinitis pigmentosa/retinal degeneration, establishing that complete absence of rod transducin alpha-subunit leads to progressive photoreceptor degeneration in addition to stationary dysfunction.\",\n      \"method\": \"Targeted next-generation sequencing of 182 retinopathy-associated genes; clinical characterization including visual field testing and fundus examination\",\n      \"journal\": \"The British journal of ophthalmology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — definitive loss-of-function allele with clinical phenotype corroborated by Gnat1 knockout mouse comparison; single case, no in vitro reconstitution\",\n      \"pmids\": [\"26472407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A novel GNAT1 missense variant p.Ile52Asn (c.155T>A) causing adCSNB affects a predicted nuclear localization signal and the first alpha-helix of the protein, distant from the GTP-binding site; subcellular localization of this and other GNAT1 CSNB mutant proteins is unaltered in mammalian overexpressing cells, indicating a mechanism distinct from mislocalization.\",\n      \"method\": \"Domain prediction; 3D structural modeling; subcellular localization assay in mammalian GNAT1-overexpressing cells; co-segregation by sequencing\",\n      \"journal\": \"BioMed research international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — subcellular localization experiment in overexpressing cells plus structural modeling; single lab, limited functional reconstitution\",\n      \"pmids\": [\"29850563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Gnat1 knockout mice (lacking rod alpha-transducin) combined with cone alpha-transducin-deficient (Gnat2) mice completely abolish rod and cone photoresponses as confirmed by ERG, yet robust visually evoked potentials persist, demonstrating that melanopsin-expressing ipRGCs can drive primary pattern-forming visual cortex responses independently of rod and cone transducin.\",\n      \"method\": \"Electroretinography (ERG); visually evoked potentials (VEP) in Gnat1-/-; Gnat2cpfl3/cpfl3 double-knockout mice\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with two orthogonal electrophysiological readouts (ERG and VEP) establishing complete functional abolition of rod/cone phototransduction via GNAT1/GNAT2 loss\",\n      \"pmids\": [\"36605613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Sildenafil (PDE6 inhibitor) completely abolished visually evoked responses in Gnat1-deficient (rod-deficient, cone-only) retinas but not in Gnat2-deficient (cone-deficient, rod-only) retinas ex vivo, demonstrating that Sildenafil preferentially inhibits cone PDE6 and that cone-selective suppression of phototransduction is sufficient to abolish Off-pathway RGC signaling.\",\n      \"method\": \"Ex vivo multi-electrode array recordings from Gnat1 and Gnat2 knockout mouse retinas; pharmacological PDE6 inhibition with Sildenafil; flash and drifting-grating stimuli\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct pharmacological/genetic dissection using knockout models with electrophysiological readout; preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2025.10.07.680926\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"The GNAT1 p.Gln200Arg variant (c.599A>G) in the Switch 2 GTPase active-site region is predicted by in silico analysis and structural modeling to impair GTPase activity and cause constitutively active signaling after photoactivation, causing autosomal dominant Riggs-type CSNB.\",\n      \"method\": \"In silico pathogenicity prediction tools; protein structural modeling; targeted NGS with Sanger sequencing confirmation; ERG\",\n      \"journal\": \"Documenta ophthalmologica. Advances in ophthalmology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — mechanistic inference based solely on computational/structural modeling without in vitro biochemical validation; single family\",\n      \"pmids\": [\"41954843\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNAT1 encodes the alpha-subunit of rod transducin, a key GTPase in the rod phototransduction cascade; it couples photoactivated rhodopsin to downstream cGMP phosphodiesterase, and disease-causing mutations either abolish effector activation (p.G38D), impair GTPase activity causing constitutive activation (p.Q200E/R), or truncate the protein causing complete loss of rod phototransduction and, with full loss-of-function alleles, progressive rod-cone degeneration in addition to stationary night blindness.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNAT1 encodes the alpha-subunit of rod transducin, the GTPase that couples photoactivated rhodopsin to the downstream cGMP phosphodiesterase effector in the rod phototransduction cascade [#0, #2]. Distinct disease-causing mutations map onto separable steps of this GTPase cycle: the p.Gly38Asp substitution yields a transducin unable to activate its downstream effector, defining a loss-of-effector-activation mechanism for autosomal dominant CSNB [#0], whereas Switch 2 active-site substitutions (p.Gln200Glu, p.Gln200Arg) impair GTPase activity and produce constitutive, light-independent signaling [#1, #8]. Complete loss of the protein, whether by a splice-disrupting nonsense allele in mice or a truncating allele in humans, abolishes rod transducin protein and rod phototransduction and, when fully null, causes progressive rod-cone/retinal degeneration in addition to stationary night blindness [#2, #4]. GNAT1 is expressed predominantly in the retina from early postnatal development [#3], and combined loss of rod (Gnat1) and cone (Gnat2) transducin abolishes all rod and cone electroretinographic responses while sparing melanopsin-driven ipRGC cortical responses, demonstrating that GNAT1 is required specifically for the rod arm of image-forming phototransduction [#6]. CSNB-associated missense variants do not act through protein mislocalization, as their subcellular distribution is unaltered in overexpressing cells [#5].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved how dominant CSNB mutations corrupt transducin function by separating an effector-activation defect from an active-site GTPase defect, establishing two distinct molecular mechanisms.\",\n      \"evidence\": \"In vitro effector activation data, trypsin protection assay, and structural modeling of p.G38D and Switch 2 p.Q200E mutants\",\n      \"pmids\": [\"17584859\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct GTPase rate measurement for the Q200E mutant in this work\", \"Single lab; effector activation data referenced from prior work\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed that disrupting Gnat1 splicing eliminates rod transducin alpha-subunit protein and abolishes rod function, providing an in vivo loss-of-function model.\",\n      \"evidence\": \"RT-PCR, immunohistochemistry, western blot, and sequencing of IRD1/IRD2 mice carrying a Tyr150Ter nonsense allele\",\n      \"pmids\": [\"19766629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address degeneration progression over time\", \"Mechanism of dominant human alleles not modeled here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended the GNAT1 disease spectrum to autosomal recessive CSNB and defined the retinal, postnatal-onset expression of the gene.\",\n      \"evidence\": \"Linkage analysis and Sanger sequencing of a consanguineous family plus quantitative ocular expression profiling for the p.D129G allele\",\n      \"pmids\": [\"22190596\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro functional reconstitution of the D129G mutant\", \"Biochemical consequence of D129G unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established that complete loss of rod transducin causes progressive retinal degeneration, not merely stationary night blindness, distinguishing null from hypomorphic outcomes.\",\n      \"evidence\": \"Targeted NGS and clinical characterization of a homozygous truncating allele, corroborated by knockout-mouse comparison\",\n      \"pmids\": [\"26472407\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case\", \"Cellular mechanism linking transducin loss to degeneration not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Ruled out protein mislocalization as the mechanism for CSNB mutants, including a variant in a predicted NLS and the first alpha-helix distant from the GTP-binding site.\",\n      \"evidence\": \"Subcellular localization assays in GNAT1-overexpressing mammalian cells plus structural modeling of p.I52N and other mutants\",\n      \"pmids\": [\"29850563\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression context may not reflect rod outer segment trafficking\", \"Functional consequence of I52N not biochemically measured\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated that GNAT1 is required for the rod arm of image-forming vision and that melanopsin ipRGCs can drive cortical responses independently of rod/cone transducin.\",\n      \"evidence\": \"ERG and VEP recordings in Gnat1-/-; Gnat2cpfl3/cpfl3 double-knockout mice\",\n      \"pmids\": [\"36605613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not dissect rod versus cone contributions to specific behaviors\", \"Human relevance of ipRGC-driven cortical signaling untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Used Gnat1 versus Gnat2 knockout retinas to pharmacologically separate rod and cone PDE6 contributions to downstream RGC signaling.\",\n      \"evidence\": \"Ex vivo multi-electrode array recordings with Sildenafil PDE6 inhibition in Gnat1 and Gnat2 knockout retinas (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.10.07.680926\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, single lab\", \"Addresses cone-pathway pharmacology rather than GNAT1 protein mechanism directly\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Linked another Switch 2 active-site variant to dominant Riggs-type CSNB via predicted impaired GTPase activity and constitutive signaling.\",\n      \"evidence\": \"In silico pathogenicity prediction, structural modeling, targeted NGS/Sanger confirmation, and ERG for p.Q200R\",\n      \"pmids\": [\"41954843\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanistic inference is purely computational without in vitro biochemical validation\", \"Single family\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How complete loss of rod transducin progresses from stationary dysfunction to photoreceptor degeneration, and the biochemical consequences of recessive missense alleles, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstituted biochemistry for D129G or I52N alleles\", \"Mechanism linking null transducin to degeneration uncharacterized\", \"Q200R constitutive-activation claim awaits biochemical confirmation\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 2, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [2, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\"rod transducin\"],\n    \"partners\": [\"RHO\", \"PDE6\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}